ECG Flow ATTR: Artificial Intelligence Enabled Early Diagnosis of Transthyretin Cardiac Amyloidosis Using Electrocardiography

28 August 2026 (11:15 - 11:30)

Organised by:

Video

Slides

Sign in for access options

About the speaker

Doctor Seyed Reza Mirjalili

University of Liverpool, Life Science Building, Liverpool (United Kingdom of Great Britain & Northern Ireland)

3 More presentations in this session

Presentation thumbnail

Mortality and hospitalization rates in 19,397 participants according to ejection fraction phenotype and country income level: The Global Congestive Heart Failure Registry.

Professor K. Branch (Seattle, US)

Presentation thumbnail

Personalised Evaluation of NT-proBNP and Clinical Characteristics in Suspected Heart Failure

Doctor K. Docherty (Glasgow, GB)

Presentation thumbnail

Proactive screening identifies unrecognized heart failure after ST-elevation myocardial infarction

Doctor C. Lenselink (Groningen, NL)

Access the full session

Session thumbnail

Late-Breaking Clinical Science on heart failure: diagnosis and prognosis registries

The Event

Event poster

ESC Congress 2026

28 August 2026 11:15 CET

You may be interested in

Congress Presentation

Targeted deployment of AI-ECG for efficient screening of transthyretin amyloid cardiomyopathy using deep learning representations of longitudinal electronic health records

31 August 2025

Congress Session

Amyloid cardiomyopathy: epidemiology, diagnosis, prognostic and treatment

13 May 2024

Congress Session

Revolutionising cardiac diagnosis: exploring deep learning in electrocardiography and beyond

30 August 2024

Congress Presentation

Artificial intelligence-enabled detection of amyloidosis on echocardiography

12 December 2024

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources